Design, synthesis, docking and biological evaluation of 4-phenyl-thiazole derivatives as autotaxin (ATX) inhibitors.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2017-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmcl.2017.07.022PMID 28743508
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Discovery of 2-[[2-Ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (GLPG1690), a First-in-Class Autotaxin Inhibitor Undergoing Clinical Evaluation for the Treatment of Idiopathic Pulmonary Fib

  2017cited by this paper
• Structure-Activity Relationships of Small Molecule Autotaxin Inhibitors with a Discrete Binding Mode.

  2017cited by this paper
• Novel Autotaxin Inhibitors for the Treatment of Osteoarthritis Pain: Lead Optimization via Structure-Based Drug Design.

  2016cited by this paper
• Development of Autotaxin Inhibitors: An Overview of the Patent and Primary Literature.

  2016cited by this paper
• Lysophosphatidic acid mediates fibrosis in injured joints by regulating collagen type I biosynthesis.

  2015cited by this paper
• (3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro-1H-indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase.

  2015cited by this paper
• Pro-fibrotic activity of lysophosphatidic acid in adipose tissue: in vivo and in vitro evidence.

  2014cited by this paper
• Functional and structural characterization of 2-amino-4-phenylthiazole inhibitors of the HIV-1 nucleocapsid protein with antiviral activity.

  2014cited by this paper
• LPA receptor signaling: pharmacology, physiology, and pathophysiology

  2014cited by this paper
• Arguing the case for the autotaxin-lysophosphatidic acid-lipid phosphate phosphatase 3-signaling nexus in the development and complications of atherosclerosis.

  2014cited by this paper
• Increased autotaxin activity in multiple sclerosis.

  2014cited by this paper
• Lysophosphatidic Acid Inhibits CD8 T-cell Activation and Control of Tumor Progression

  2013cited by this paper
• Lysophospholipid Receptors: Signaling and Biochemistry

  2013cited by this paper
• Pleiotropic activity of lysophosphatidic acid in bone metastasis.

  2013cited by this paper
• Autotaxin in embryonic development.

  2013cited by this paper
• Lysophosphatidic acid (LPA) signalling in cell migration and cancer invasion: A focussed review and analysis of LPA receptor gene expression on the basis of more than 1700 cancer microarrays

  2013cited by this paper
• Expression of lysophosphatidic acid, autotaxin and acylglycerol kinase as biomarkers in diabetic retinopathy

  2013cited by this paper
• Effect of inhibition of the lysophosphatidic acid receptor 1 on metastasis and metastatic dormancy in breast cancer.

  2012cited by this paper
• Controlling cancer through the autotaxin-lysophosphatidic acid receptor axis.

  2012cited by this paper
• Insights into the pharmacological relevance of lysophospholipid receptors

  2012cited by this paper
• Autotaxin emerges as a therapeutic target for idiopathic pulmonary fibrosis: limiting fibrosis by limiting lysophosphatidic acid synthesis.

  2012cited by this paper
• Autotaxin and LPA receptor signaling in cancer

  2011cited by this paper
• LPA Is a Chemorepellent for B16 Melanoma Cells: Action through the cAMP-Elevating LPA5 Receptor

  2011cited by this paper
• Autotaxin as a novel serum marker of liver fibrosis.

  2011cited by this paper
• Lysophosphatidic acid production and action: critical new players in breast cancer initiation and progression

  2010cited by this paper
• Autotaxin and lysophospholipids in rheumatoid arthritis.

  2010cited by this paper
• A Novel Autotaxin Inhibitor Reduces Lysophosphatidic Acid Levels in Plasma and the Site of Inflammation

  2010cited by this paper
• Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases.

  2009cited by this paper
• Expression of Autotaxin and Acylglycerol kinase in prostate cancer: Association with cancer development and progression

  2009cited by this paper
• Lysophosphatidic acid (LPA) and angiogenesis

  2008cited by this paper
• The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak

  2008cited by this paper
• LPA1 receptor activation promotes renal interstitial fibrosis.

  2007cited by this paper
• In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.

  2005cited by this paper
• Expression, regulation and function of autotaxin in thyroid carcinomas

  2004cited by this paper
• Identification of Human Plasma Lysophospholipase D, a Lysophosphatidic Acid-producing Enzyme, as Autotaxin, a Multifunctional Phosphodiesterase*

  2002cited by this paper
• Expression of autotaxin (NPP-2) is closely linked to invasiveness of breast cancer cells

  2002cited by this paper
• Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization

  2001cited by this paper
• Expression of autotaxin mRNA in human hepatocellular carcinoma.

  1999cited by this paper
• Autotaxin expression in non-small-cell lung cancer.

  1999cited by this paper
• Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein.

  1992cited by this paper
• Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins.

  1989cited by this paper

• Modulation of Stem Cell Survival and Engraftment: Implications for Stem Cell-Based Therapy

  2025cites this paper
• Recent research advances in ATX inhibitors: An overview of primary literature.

  2023cites this paper
• Artificial Intelligence, Big data and Machine Learning approaches in Preci-sion Medicine & Drug Discovery.

  2021cites this paper
• Design and Development of Autotaxin Inhibitors

  2021cites this paper
• Idiopathic pulmonary fibrosis: Molecular mechanisms and potential treatment approaches.

  2020cites this paper
• Pharmacophoric Site Identification and Inhibitor Design for Autotaxin

  2019cites this paper
• Multi-target compounds acting in cancer progression: Focus on thiosemicarbazone, thiazole and thiazolidinone analogues.

  2019cites this paper
• Discovery and optimization of ATX inhibitors via modeling, synthesis and biological evaluation.

  2018cites this paper
• Development and therapeutic potential of autotaxin small molecule inhibitors: From bench to advanced clinical trials

  2018cites this paper